Armistice Capital »

Cingulate shares owned by Armistice Capital

Quarter-by-quarter ownership of Cingulate (CING) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cingulate

Tip: Access up to 7 years of quarterly data

All positions including Cingulate held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cingulate by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $157k 490k 0.32

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Cingulate

Armistice Capital
Tower Research Capital
Qube Research & Technologies

View all funds holding Cingulate